Reports
Sale
Global Centesis Catheters Market Size, Share, Growth, Trends: By Type: Small-bore Centesis Catheters, Large-bore Centesis Catheters; By Procedure: Paracentesis, Thoracentesis, Arthrocentesis, Amniocentesis, Others; By Applications: Diagnostic Applications, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Centesis Catheters Market Outlook
The global centesis catheters market size was valued at USD 500.6 million in 2023, driven by the increasing investments by key players in research and development activities across the globe. The market size is anticipated to grow at a CAGR of 6.6% during the forecast period of 2024-2032 to achieve a value of USD 888.6 million by 2032.
Global Centesis Catheters Market Overview
Centesis catheters are used to drain out the excess fluids from the pleural cavities on the body or abdomen which sometimes could be infected. The drainage of these fluids results in reduced pressure on the organs which may cause other severe conditions if left untreated.
The increasing technological advancements in the development of catheters are driving the global centesis catheters market demand. The increasing preference for minimally invasive surgical procedures is also driving the market growth as the catheters are inserted by making small incisions on the targeted area of the body. The market is further expected to be driven by the launch of new innovative developments by key players. Shockwave Medical, a cardiovascular medical device company based in Santa-Clara, California, announced full commercial availability for its newly developed C2+ coronary intravascular lithotripsy (IVL) catheter which can be used in severely calcified coronary artery disease.
Rising Strategic Acquisitions
In April 2023, Shockwave Medical completed its acquisition of Neovasc for USD 147 million. A sum of USD 27.25 per share was paid to Nevosac by Shockwave Medical. This deal acquired an enterprise value of nearly USD 100 million . Such acquisitions have the potential to influence the global centesis catheters market growth positively. Following this acquisition, Shockwave is expected to gain access to Neovasc's technologies, expertise, and intellectual property related to catheters.
The market is expected to experience competition and expansion owing to such acquisitions. Acquisitions like these are major factors responsible for increased research and development activities in the market. The increased research and development activities are directly related to increased investment by the key players to stay ahead in the market.
Additionally, in October 2023, leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie), acquired Urotronic, Inc. (Urotronic), a private medical device company that developed Optilume® drug-coated balloon technology used in interventional urology to treat urethral strictures and benign prostatic hyperplasia (BPH) or enlarged prostate conditions.
This acquisition has the potential to bring more advanced and more effective solutions in interventional urology. This could also result in improved treatment options among patients suffering from urethral strictures and benign prostatic hyperplasia (BPH) or enlarged prostate conditions.
FDA Approvals to Aid the Centesis Catheters Market Growth
The market growth is also driven by the FDA approvals resulting in the launch of new products in the market. In May 2023, Abbott announced FDA approval of its TactiFlex Ablation Catheter. The company claims this product to be sensor-enabled, which is the world’s first ablation catheter with a flexible tip and contact force technology. The TactiFlex catheter can be used in conjunction with Abbott's EnSite X EP System to provide physicians with a more precise visualization of the heart's anatomy. Abbott officials have stated that their next-gen radiofrequency ablation system will improve the efficiency and accuracy of arrhythmia treatments.
Rise in Funds and Investments
In November 2023, Laborie Medical Technologies Corp., a leading diagnostic and therapeutic medical technology company, announced a strategic equity investment in Bright Uro, an early-stage medical technology company headquartered in Irvine, CA. Bright Uro is developing the Glean Urodynamic System™, a wireless, catheter-free, urodynamic monitoring system intended to quantify the pressure characteristics of the lower urinary tract. The catheter-free approach aligns with the increasing preference for minimally invasive and patient-friendly diagnostic technologies, more efficient and comfortable alternatives to address lower urinary tract issues, propelling the market growth.
Global Centesis Catheters Market Segmentations
Market Breakup by Type
- Small-bore Centesis Catheters
- Large-bore Centesis Catheters
Market Breakup by Procedure
- Paracentesis
- Thoracentesis
- Arthrocentesis
- Amniocentesis
- Others
Market Breakup by Applications
- Diagnostic Applications
- Therapeutic Application
- Palliative Care Applications
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Centesis Catheters Market Regional Analysis
The market has been witnessing significant growth due to the increased use of centesis catheters in several diseases. The increasing prevalence of chronic diseases such as cancer and lung-related lethal diseases is driving the market growth. To treat this condition, thoracentesis is performed to examine and treat the pleural effusions. To remove the excess fluids from the abdomen, paracentesis is used where a thin needle is inserted to relieve the pressure from the abdomen of the patient. The increasing popularity of image-guided centesis procedures among healthcare professionals to treat patients is also likely to contribute to the rising centesis catheters market share.
In May 2023, Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved the company's TactiFlex™ Ablation Catheter, Sensor Enabled™, the world's first ablation catheter with a flexible tip and contact force technology. More than 37 million people worldwide live with AFib3, and it is expected to more than double by 2050. An additional five million cases are diagnosed every year, indicating a growing health challenge that demands innovative solutions for patients and their physicians.
The TactiFlex catheter is used to perform an ablation procedure to treat atrial fibrillation (AFib), the most common abnormal heart rhythm, and can result in reduced procedure times and better safety when compared to the company's previous generation catheters. This FDA approval enables the world's first ablation catheter with a flexible tip and contact force technology to fill a crucial gap of unmet needs in the medical sector, bolstering the global centesis catheters market demand.
Global Centesis Catheters Market: Competitor Landscape
In October 2023, a leader in smart infusion therapy, B. Braun Medical Inc. (B. Braun), announced the launch of its new Introcan Safety® 2 IV Catheter with Multi-Access Blood Control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun in a long line of passive needlestick prevention catheters. In addition to automatic needlestick protection, clinicians are protected from blood exposure by a blood control feature every time the hub is accessed which reduces the risk of bloodborne pathogen exposure throughout the IV process.
The key features of the centesis catheters market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- B. Braun Melsungen AG
- AngloDynamics
- Boston Scientific Corporation
- Becton, Dickinson and Company
- Cardinal Health
- Galt Medical Corp
- Medtronic Plc
- Merit Medical Systems
- Teleflex Incorporated
- Avanos Medical, Inc.
- Axiom Medical Consulting, LLC
- Medical Components, Inc.
- Mermaid Medical A/S
- Neuromedex GmbH
- Ningbo Honde Medical Instruments Co. Ltd.
- AngioDynamics, Inc.
- Argon Medical Devices, Inc.
- KM Medical
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Procedure |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Centesis Catheters Market Overview
3.1 Global Centesis Catheters Market Historical Value (2017-2023)
3.2 Global Centesis Catheters Market Forecast Value (2024-2032)
4 Global Centesis Catheters Market Landscape
4.1 Global Centesis Catheters Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Centesis Catheters Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Procedure
4.2.3 Analysis by Applications
5 Global Centesis Catheters Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.3.6 Key Demand Indicators
5.4 Key Price Indicators
5.5 Industry Events, Initiatives, and Trends
5.6 Value Chain Analysis
6 Global Centesis Catheters Market Segmentation (2017-2032)
6.1 Global Centesis Catheters Market (2017-2032) by Type
6.1.1 Market Overview
6.1.2 Small-bore Centesis Catheters
6.1.3 Large-bore Centesis Catheters
6.2 Global Centesis Catheters Market (2017-2032) by Procedure
6.2.1 Market Overview
6.2.2 Paracentesis
6.2.3 Thoracentesis
6.2.4 Arthrocentesis
6.2.5 Amniocentesis
6.2.6 Others
6.3 Global Centesis Catheters Market (2017-2032) by Applications
6.3.1 Market Overview
6.3.2 Diagnostic Applications
6.3.3 Therapeutic Application
6.3.4 Palliative Care Applications
6.4 Global Centesis Catheters Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgical Centers
6.4.4 Others
6.5 Global Centesis Catheters Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Centesis Catheters Market (2017-2032)
7.1 North America Centesis Catheters Market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Small-bore Centesis Catheters
7.1.3 Large-bore Centesis Catheters
7.2 North America Centesis Catheters Market (2017-2032) by Applications
7.2.1 Market Overview
7.2.2 Diagnostic Applications
7.2.3 Therapeutic Application
7.2.4 Palliative Care Applications
7.3 North America Centesis Catheters Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Centesis Catheters Market (2017-2032)
8.1 Europe Centesis Catheters Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Small-bore Centesis Catheters
8.1.3 Large-bore Centesis Catheters
8.2 Europe Centesis Catheters Market (2017-2032) by Applications
8.2.1 Market Overview
8.2.2 Diagnostic Applications
8.2.3 Therapeutic Application
8.2.4 Palliative Care Applications
8.3 Europe Centesis Catheters Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Centesis Catheters Market (2017-2032)
9.1 Asia Pacific Centesis Catheters Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Small-bore Centesis Catheters
9.1.3 Large-bore Centesis Catheters
9.2 Asia Pacific Centesis Catheters Market (2017-2032) by Applications
9.2.1 Market Overview
9.2.2 Diagnostic Applications
9.2.3 Therapeutic Application
9.2.4 Palliative Care Applications
9.3 Asia Pacific Centesis Catheters Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Centesis Catheters Market (2017-2032)
10.1 Latin America Centesis Catheters Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Small-bore Centesis Catheters
10.1.3 Large-bore Centesis Catheters
10.2 Latin America Centesis Catheters Market (2017-2032) by Applications
10.2.1 Market Overview
10.2.2 Diagnostic Applications
10.2.3 Therapeutic Application
10.2.4 Palliative Care Applications
10.3 Latin America Centesis Catheters Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Centesis Catheters Market (2017-2032)
11.1 Middle East and Africa Centesis Catheters Market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Small-bore Centesis Catheters
11.1.3 Large-bore Centesis Catheters
11.2 Middle East and Africa Centesis Catheters Market (2017-2032) by Applications
11.2.1 Market Overview
11.2.2 Diagnostic Applications
11.2.3 Therapeutic Application
11.2.4 Palliative Care Applications
11.3 Middle East and Africa Centesis Catheters Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 B. Braun Melsungen AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 AngloDynamics
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Boston Scientific Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Becton, Dickinson and Company
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Cardinal Health
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Galt Medical Corp
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Medtronic Plc
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Merit Medical Systems
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Teleflex Incorporated
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Avanos Medical, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Axiom Medical Consulting, LLC
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Medical Components, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Mermaid Medical A/S
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 Neuromedex GmbH
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 Ningbo Honde Medical Instruments Co. Ltd.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
17.16 AngioDynamics, Inc.
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisition
17.16.5 Certifications
17.17 Argon Medical Devices, Inc.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisition
17.17.5 Certifications
17.18 KM Medical
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisition
17.18.5 Certifications
List not exhaustive
18 Global Centesis Catheters Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 500.6 million in 2023, driven by the innovation in development.
The market is anticipated to grow at a CAGR of 6.6% during the forecast period of 2024-2032 and is likely to reach a market value of USD 888.6 million by 2032.
The increase in the incidence of chronic diseases and accumulation of excessive fluids in pleural cavities or abdomen areas, increasing preference for minimally invasive devices, strategic acquisitions, increasing FDA approvals, product launches, and rising technological advancements are the major factors driving the market growth.
Increasing investment activities in the development and design of these catheters such as Laborie Medical Technologies Corp., announcing a strategic equity investment in Bright Uro is the major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Two types of centesis catheters are small-bore centesis catheters and large-bore centesis catheters.
Centesis catheters are used in paracentesis, thoracentesis, arthrocentesis, and amniocentesis, among others.
They find wide applications in diagnostic, therapeutic, and palliative care applications, among others.
The end users in the market include hospitals and ambulatory surgical centers, among others.
Key players involved in the market are B. Braun Melsungen AG, AngloDynamics, Boston Scientific Corporation, Becton, Dickinson and Company, Cardinal Health, Galt Medical Corp, Medtronic Plc, Merit Medical Systems, Teleflex Incorporated, Avanos Medical, Inc., Axiom Medical Consulting, LLC, Medical Components, Inc., Mermaid Medical A/S, Neuromedex GmbH, Ningbo Honde Medical Instruments Co. Ltd., AngioDynamics, Inc., Argon Medical Devices, Inc., and KM Medical.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER